The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation

Immune checkpoint inhibitors represent some of the most important cancer treatments developed in the last 20 y. However, existing immunotherapy approaches benefit only a minority of patients. Here, we provide evidence that the aryl hydrocarbon receptor (AhR) is a central player in the regulation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kenison, Jessica E., Wang, Zhongyan, Yang, Kangkang, Snyder, Megan, Quintana, Francisco J., Sherr, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2021
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126867/
https://www.ncbi.nlm.nih.gov/pubmed/33941684
http://dx.doi.org/10.1073/pnas.2012692118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126867/
https://www.ncbi.nlm.nih.gov/pubmed/33941684
http://dx.doi.org/10.1073/pnas.2012692118

Ejemplares similares